Hello! At JNPMEDI, weโve prepared an update on the medical device clinical trial plans approved in October.
Shall we take a closer look? ๐
The clinical trial plans approved in October are making exciting strides in cancer research, with a strong focus on developing innovative diagnostic and predictive models through the use of image analysis and artificial intelligence technologies.
These technologies enable early cancer detection and the formulation of effective treatment plans, playing a crucial role in the realization of personalized medicine for patients.
These studies are expected to be actively applied in healthcare settings, bringing exciting contributions to patient treatment and making a positive impact in the future.
The clinical trials approved on October 30th include a clinical trial for a medical device based on diffuse optical spectroscopy imaging technology. This technology is used to non-invasively visualize and precisely analyze the characteristics of cancerous tissues.
Around cancerous tissues, new blood vessels are often formed, leading to an increase in hemoglobin concentration. Hemoglobin absorbs most light in the ultraviolet and visible light spectrum, but its absorption decreases in the near-infrared range (650nmโ1000nm), allowing light to penetrate deeper into tissues. As a result, cancer tissues with higher hemoglobin concentrations can be effectively distinguished from other tissues.
Based on this principle, diffuse optical spectroscopy imaging technology can distinguish cancerous tissues in the near-infrared range and non-invasively visualize the internal structures and changes of biological tissues. Particularly, it enables accurate diagnosis and image reproduction even in biological tissues with high scattering, thereby enhancing its diagnostic value.
As of now, there have been approximately 6 clinical trials for medical devices based on diffuse optical spectroscopy imaging technology approved since 2021, all of which are focused on breast cancer research.
Weโll be back next month with more updates on medical device clinical trial approvals and exciting information ๐
โถ References
- Medical Device Safety Bookstore : https://emedi.mfds.go.kr/portal
- Research Trends in Breast Cancer Using Diffuse Optical Spectroscopy and Imaging Technology by Jaekwan Kim
Hello! At JNPMEDI, weโve prepared an update on the medical device clinical trial plans approved in October.
Shall we take a closer look? ๐
The clinical trial plans approved in October are making exciting strides in cancer research, with a strong focus on developing innovative diagnostic and predictive models through the use of image analysis and artificial intelligence technologies.
These technologies enable early cancer detection and the formulation of effective treatment plans, playing a crucial role in the realization of personalized medicine for patients.
These studies are expected to be actively applied in healthcare settings, bringing exciting contributions to patient treatment and making a positive impact in the future.
The clinical trials approved on October 30th include a clinical trial for a medical device based on diffuse optical spectroscopy imaging technology. This technology is used to non-invasively visualize and precisely analyze the characteristics of cancerous tissues.
Around cancerous tissues, new blood vessels are often formed, leading to an increase in hemoglobin concentration. Hemoglobin absorbs most light in the ultraviolet and visible light spectrum, but its absorption decreases in the near-infrared range (650nmโ1000nm), allowing light to penetrate deeper into tissues. As a result, cancer tissues with higher hemoglobin concentrations can be effectively distinguished from other tissues.
Based on this principle, diffuse optical spectroscopy imaging technology can distinguish cancerous tissues in the near-infrared range and non-invasively visualize the internal structures and changes of biological tissues. Particularly, it enables accurate diagnosis and image reproduction even in biological tissues with high scattering, thereby enhancing its diagnostic value.
As of now, there have been approximately 6 clinical trials for medical devices based on diffuse optical spectroscopy imaging technology approved since 2021, all of which are focused on breast cancer research.
Weโll be back next month with more updates on medical device clinical trial approvals and exciting information ๐
โถ References
- Medical Device Safety Bookstore : https://emedi.mfds.go.kr/portal
- Research Trends in Breast Cancer Using Diffuse Optical Spectroscopy and Imaging Technology by Jaekwan Kim